ZELTIQ™ is a global medical device company that developed its patented, noninvasive, clinically proven procedure to selectively reduce fat known as CoolSculpting™. CoolSculpting™ is cleared in the United States, Canada, the European Union, and other international markets for non-invasive fat layer reduction.
CoolSculpting™ is unique in the fact that, unlike most other fat reduction techniques, it involves no needles, surgery or downtime. The procedure is performed by a non-invasive applicator delivering precisely controlled cooling to the treatment area, which is specifically targeting underlying fat. This leaves the surface skin tissue unaffected. CoolSculpting™ procedures usually last about one to two hours.
The CoolSculpting™ breakthrough is based on extensive scientific research demonstrating that fat cells are more susceptible to extreme cold and can be selectively, painlessly, and permanently destroyed using a process known as Cryolipolysis™. Beginning several weeks after the procedure, cooled fat cells begin a process called apoptosis (natural cell death), where they will begin to shrink and disappear.
CoolSculpting™ by ZELTIQ™ is not intended to be a weight-reduction program substitute for overweight individuals. Candidates that can benefit most from the CoolSculpting™ procedure are people near their ideal body weight who eat well and exercise regularly, but have pockets of fat that have not responded to a healthy lifestyle. These individuals are seeking long-lasting spot reduction for this specific area of fat, but they aren’t considering a surgical procedure with its expense, downtime, and safety risks.